I. Cochereau

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Burden of disease from inadequate water, sanitation and hygiene for selected adverse health outcomes: An updated analysis with a focus on low- and middle-income countries

A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, dexamethasone 0.1% alone, and vehicle in the treatment of subjects with blepharitis

TFOS DEWS II Diagnostic Methodology report

Ocular Drug Delivery

TFOS DEWS II pathophysiology report

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK

TFOS DEWS II Epidemiology Report

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

TFOS DEWS II Management and Therapy Report

Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis

Treatment of Blepharitis: Recent Clinical Trials

Anterior Segment and External Ocular Disorders Associated with Human Immunodeficiency Virus Disease

One man's poison is another man's meat: Using azithromycin-induced phospholipidosis to promote ocular surface health

Baseline Factors Predictive of Visual Prognosis in Acute Postoperative Bacterial Endophthalmitis in Patients Undergoing Cataract Surgery

Can Tetracycline Antibiotics Duplicate the Ability of Azithromycin to Stimulate Human Meibomian Gland Epithelial Cell Differentiation?

Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin

Meibomian Glands and Ocular Surface Inflammation

Silver nanoparticles as a new generation of antimicrobials

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

Clinical practice guidelines for antimicrobial prophylaxis in surgery

Epidemiology and control of trachoma: systematic review

Effect of Eye Pigmentation on Transscleral Drug Delivery

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Cataracts

Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis

Antibioprophylaxie en chirurgie ophtalmologique. À propos des recommandations de l’AFSSAPS

Systemic Prophylaxis of Experimental Staphylococcal Endophthalmitis: Comparative Efficacy of Sparfloxacin, Peftoxacin, Imipenem, Vancomycin, and Amikacin

3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children

Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial

Uveitis in patients treated with intravenous cidofovir

Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits

Ocular and orbital side-effects of checkpoint inhibitors: a review article

Tear Concentrations of Azithromycin following Topical Administration of a Single Dose of Azithromycin 0.5%, 1.0%, and 1.5% Eyedrops (T1225) in Healthy Volunteers